Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEREO open-label adalimumab study in psoriatic arthritis
2005-001185-14Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Apr 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of adalimumab in psoriatic arthritis (PsA), sponsored by Abbott Laboratories. Primary endpoint: Safety. Started Apr 2005; status: completed.
02
Drugs
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2005-001185-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001185-14.